Margaret Wecker, PhD is the Global Head for the Regulatory Program at CVIA. She has more than 25 years of clinical research experience. Prior to joining PATH as the Senior Regulatory Strategist, she was the Director of Scientific Operations for the HIV Vaccine Trials Network at the Fred Hutchinson Cancer Research Center in Seattle, Washington. In this role Dr. Wecker was responsible for management oversight of five operational units and directed global site development, expansion and site management. Prior to joining the HVTN, she was a Senior Associate Director of Clinical Research at Boehringer Ingelheim Pharmaceuticals, Inc. In this role, she was responsible for global drug development programs of respiratory products. She has lead programs from first in human clinical trials to post marketing support including responsibility for registration programs in the US and Europe. Dr. Wecker received her PhD in Pharmacology from the University of Rochester, and a Bachelor’s Degree of Science in Biochemistry from Brown University.